EDN1 exhibited context-dependent dysregulation, with significant upregulation in 9 cancers (including CRC, gastric, and ovarian cancers) and downregulation in 9 others (e.g., breast, prostate) (Fig. 1A). This evidence concerns the gene EDN1 and cancer.